drugset / Trial / NCT02268968

Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal CPAP Continuous Positive Airway Pressure

NCT02268968

Phase 1 Completed 60 enrolled Mansoura University Children Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The main purpose of this study is to evaluate the relative efficacy of topical lidocaine on reducing pain associated with the application of nasal CPAP in preterm infants

Timeline

Start
2013-10
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 0.3 unknown Topical

Indications

No indication recorded.